These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8525804)

  • 1. Muscle regeneration and mitochondrial calmitine increase in the dystrophic dy/dy mouse after intramuscular chlorpromazine injection.
    Lucas-Heron B; Louboutin JP; Ollivier B; Schmitt N
    Acta Neuropathol; 1995; 90(3):299-304. PubMed ID: 8525804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A drug inhibits the mitochondrial protease inducing calmitine deficiency in skeletal muscle of patients with Duchenne's muscular dystrophy and dy/dy dystrophic mice.
    Lucas-Heron B
    Biochem Biophys Res Commun; 1997 Mar; 232(2):559-61. PubMed ID: 9125222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degeneration and subsequent regeneration of mouse skeletal muscle after a single injection of chlorpromazine: changes in mitochondrial calmitine and calcium content.
    Schmitt N; Lucas-Héron B; Ollivier B; Mussini JM
    J Neurol Sci; 1991 Sep; 105(1):44-8. PubMed ID: 1795168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscular dystrophy: possible role of mitochondrial deficiency in muscle degeneration processes.
    Lucas-Heron B; Schmitt N; Ollivier B
    J Neurol Sci; 1990 Mar; 95(3):327-34. PubMed ID: 2358824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mdx mouse skeletal muscle: could a mitochondrial factor be responsible for the absence of progressive necrosis?
    Lucas-Heron B; Schmitt N; Ollivier B
    Neurosci Lett; 1994 Mar; 169(1-2):97-100. PubMed ID: 8047301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in mitochondrial calmitine and calcium in rat denervated skeletal muscle after injection of a myotoxic drug, chlorpromazine.
    Schmitt N; Lucas-Heron B; Ollivier B
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Mar; 104(3):389-93. PubMed ID: 8103430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of torbafylline on mitochondrial calmitine in mouse skeletal muscle regeneration after injection of a myotoxic drug.
    Lucas-Héron B; Ollivier B; Schmitt N
    J Neurol Sci; 1993 Aug; 118(1):97-100. PubMed ID: 8229057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a maturation defect related to calcium in muscle mitochondria from dystrophic mice and Duchenne and Becker muscular dystrophy patients.
    Lucas-Héron B; Mussini JM; Ollivier B
    J Neurol Sci; 1989 May; 90(3):299-306. PubMed ID: 2738610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does calmitine, a protein specific for the mitochondrial matrix of skeletal muscle, play a key role in mitochondrial function?
    Lucas-Heron B; Le Ray B; Schmitt N
    FEBS Lett; 1995 Nov; 374(3):309-11. PubMed ID: 7589560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe mitochondrial anomaly in dystrophic mouse skeletal muscle.
    Lucas-Heron B; Loirat MJ; Ollivier B
    Neurosci Lett; 1988 Jul; 90(1-2):147-51. PubMed ID: 3412635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of a calmitine-specific protease inhibitor in skeletal muscle mitochondria of patients with Duchenne's muscular dystrophy.
    Lucas-Heron B
    Biochem Biophys Res Commun; 1996 Aug; 225(3):701-4. PubMed ID: 8780677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle of patients with Duchenne's muscular dystrophy: evidence of a mitochondrial proteolytic factor responsible for calmitine deficiency.
    Lucas-Heron B
    Biochem Biophys Res Commun; 1996 Jun; 223(1):31-5. PubMed ID: 8660374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related calmitine distribution in mitochondria of normal and mdx mouse skeletal muscle.
    Lucas-Héron B; Schmitt N; Ollivier B
    J Neurol Sci; 1990 Nov; 99(2-3):349-53. PubMed ID: 2086733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capillaries with fenestrations around regenerating muscle fibers in the soleus muscle of the dystrophic (dy) mouse.
    Oki S; Desaki J; Matsuda Y; Shibata T; Okumura H
    J Orthop Sci; 1998; 3(1):67-70. PubMed ID: 9654557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscular transverse relaxation time measurement by magnetic resonance imaging at 4 Tesla in normal and dystrophic dy/dy and dy(2j)/dy(2j) mice.
    Tardif-de Géry S; Vilquin J; Carlier P; Raynaud JS; Wary C; Schwartz K; Leroy-Willig A
    Neuromuscul Disord; 2000 Oct; 10(7):507-13. PubMed ID: 10996783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: I. Clenbuterol.
    Hayes A; Williams DA
    J Neurol Sci; 1998 May; 157(2):122-8. PubMed ID: 9619633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial calcium content and oxidative phosphorylation in heart and skeletal muscle of dystrophic mice.
    Nylen EG; Wrogemann K
    Exp Neurol; 1983 Apr; 80(1):69-80. PubMed ID: 6832274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscular dystrophy: centronucleation may reflect a compensatory activation of defective myonuclei.
    Totsuka T; Watanabe K; Uramoto I; Sakuma K; Mizutani T
    J Biomed Sci; 1998; 5(1):54-61. PubMed ID: 9570514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative freeze-fracture study of plasma membrane of dystrophic skeletal muscles in dy/dy mice with merosin (laminin 2) deficiency and mdx mice with dystrophin deficiency.
    Shibuya S; Wakayama Y; Oniki H; Kojima H; Saito M; Etou T; Nonaka I
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):123-31. PubMed ID: 9160897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-related defects in cardiac and skeletal muscles of dystrophic mice.
    Lucas-Heron B; Loirat MJ; Ollivier B; Leoty C
    Comp Biochem Physiol B; 1987; 86(2):295-301. PubMed ID: 2952438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.